NFKB1 and hepatocellular carcinoma: These mice are deficient in essential NF-κB modulators, lack hepatocyte NF-κB activation abilities, and can regulate apoptotic enzymes and apoptosis-related proteins, which reduces HCC development, thus suggesting that the anti-apoptotic function of NF-κB may prevent HCC development by inhibiting compensatory proliferation [46,47].